sirolimus has been researched along with Angiokeratoma* in 2 studies
1 review(s) available for sirolimus and Angiokeratoma
Article | Year |
---|---|
Use of topical rapamycin in acral pseudolymphomatous angiokeratoma of children (APACHE): A report of two cases and review of the literature.
Acral pseudolymphomatous angiokeratoma of children (APACHE) is a rare, benign disease characterized clinically by multiple, asymptomatic, erythematous papules in the acral regions. We report APACHE in a 12-year-old girl with erythematous-violaceous papules on the lateral dorsum of her foot and toes, and a 3-year-old girl with erythematous papules on the plantar aspect of her foot. Topical rapamycin ointment improved the lesions and both patients tolerated the medication well. Topical rapamycin appears to be a potentially efficacious, well-tolerated, non-invasive therapy in APACHE, although further studies are needed. Topics: Angiokeratoma; APACHE; Child; Child, Preschool; Female; Humans; Pseudolymphoma; Sirolimus; Skin Neoplasms | 2020 |
1 other study(ies) available for sirolimus and Angiokeratoma
Article | Year |
---|---|
Topical sirolimus for treatment of a solitary angiokeratoma.
Angiokeratomas are benign vascular neoplasms that arise as solitary or multiple lesions, most commonly treated with excision, electrodessication, cryotherapy, or laser therapies. This case presents a young female whose solitary angiokeratoma was treated with topical 1% sirolimus cream, improving the appearance, symptoms, and size of the lesion. Topical sirolimus cream may be a noninvasive treatment option for angiokeratomas with fewer risks than standard therapy that may be feasible and preferable for some patients. Topics: Angiokeratoma; Female; Humans; Laser Therapy; Sirolimus; Skin Neoplasms | 2020 |